The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

BCRX FINANCIAL STATEMENTS

BioCryst Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

BCRXBioCryst Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-500 M0500 M1 B202020212022202420252026

Profit Funnel

Q2 2026 · TTM
Revenue940.6 M $Gross Profit221.2 M $ · 24%Operating Income-313.2 M $ · -33%Pre-tax Income-381.2 M $ · -41%Net Income to Owners-384.7 M $ · -41%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue940.6 M $+68.7%
Gross Profit221.2 M $-59.1%
Operating Income-313.2 M $-677.8%
EBITDA-302.9 M $-577.4%
Net Income to Owners-384.7 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
-500 M0500 M1 B202020212022202420252026

Capital Structure

Q2 2026
Total Assets557.9 M
  • Current Liabilities208.8 M $21%
  • Long-term Liabilities803.3 M $79%

Key Figures

YoY change
Total Assets557.9 M $+22.0%
Total Liabilities1 B $+15.2%
Total Equity-454.3 M $—
Cash & ST Investments352.6 M $+35.6%
Total Debt409.9 M $-41.7%
Net Debt254.9 M $-58.6%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M0200 M202020212022202420252026

Cash Flow Bridge

Q2 2026 · TTM
0200 M359.9 M $Operating-448.7 M $Investing140.9 M $Financing52 M $Net Change

Key Figures

YoY change
Operating Cash Flow359.9 M $+2,039.9%
Capital Expenditures2.8 M $+161.2%
Free Cash Flow357.1 M $+2,165.8%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on BCRX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.